Arshad Najma, Mehreen Arifa, Liaqat Iram, Arshad Muhammad, Afrasiab Humera
Department of Zoology, University of the Punjab, Lahore, Punjab, Pakistan.
Department of Zoology, Government College University, Lahore, Punjab, Pakistan.
BMC Complement Altern Med. 2017 Nov 23;17(1):498. doi: 10.1186/s12906-017-2001-z.
Recently, we reported high in vitro antibacterial efficacy of Althaea officinalis, Ziziphus jujuba, Cordia latifolia and Thymus vulgaris out of a total 21 plants against wide range of bacteria including MRSA. This study was therefore, designed to confirm efficacy of these four herbs against MRSA in an animal model.
A pilot study was conducted to establish the dose of S. aureus (KY698020) required to induce clinical infection. Afterword, in main trial, efficacy of aforementioned plant extracts on the course of sore throat was checked by evaluating general health, gross lesion score, bacterial load and hematology in mice.
Pilot study revealed that 40 μl dose of 10 CFU/ml could induce infection which persist upto 08 days post infection. Mice treated with T. vulgaris and Z. jujuba showed reduction in gross lesion score of both heart and lungs. Treatment with only some plants could significantly decrease bacterial load of throat (T. vulgaris) heart, blood and joint (C. latifolia, and T. vulagris). Hematological indicators confirmed in vivo control of MRSA infection in all treatment groups except A. officinalis.
This is first report confirming in vivo anti-MRSA potential of C. latifolia and T. vulgaris and highlight the need to explore bioactive constituents of these plants. Moreover, previously reported in vitro antibacterial efficiency of A. officinalis could not be validated in current study.
最近,我们报道了在总共21种植物中,药蜀葵、枣、阔叶破布木和百里香对包括耐甲氧西林金黄色葡萄球菌(MRSA)在内的多种细菌具有很高的体外抗菌效力。因此,本研究旨在在动物模型中证实这四种草药对MRSA的疗效。
进行了一项初步研究,以确定诱导临床感染所需的金黄色葡萄球菌(KY698020)剂量。此后,在主要试验中,通过评估小鼠的总体健康状况、大体病变评分、细菌载量和血液学,检查上述植物提取物对喉咙痛病程的疗效。
初步研究表明,40μl剂量的10 CFU/ml可诱导感染,感染可持续至感染后8天。用百里香和枣处理的小鼠心脏和肺部的大体病变评分降低。仅用某些植物处理可显著降低喉咙(百里香)、心脏、血液和关节(阔叶破布木和百里香)的细菌载量。血液学指标证实,除药蜀葵外,所有治疗组的MRSA感染在体内得到控制。
这是首次证实阔叶破布木和百里香体内抗MRSA潜力的报告,并强调需要探索这些植物的生物活性成分。此外,先前报道的药蜀葵的体外抗菌效率在当前研究中未得到验证。